Review of Platensimycin and Platencin: Inhibitors of β-Ketoacyl-acyl Carrier Protein (ACP) Synthase III (FabH)

Molecules. 2015 Sep 3;20(9):16127-41. doi: 10.3390/molecules200916127.

Abstract

Platensimycin and platencin were successively discovered from the strain Streptomyces platensis through systematic screening. These natural products have been defined as promising agents for fighting multidrug resistance in bacteria by targeting type II fatty acid synthesis with slightly different mechanisms. Bioactivity studies have shown that platensimycin and platencin offer great potential to inhibit many resistant bacteria with no cross-resistance or toxicity observed in vivo. This review summarizes the general information on platensimycin and platencin, including antibacterial and self-resistant mechanisms. Furthermore, the total synthesis pathways of platensimycin and platencin and their analogues from recent studies are presented.

Keywords: analogues; antibacterial activities; drug resistance; platencin; platensimycin; synthesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adamantane / chemistry
  • Adamantane / pharmacology*
  • Aminobenzoates / chemistry
  • Aminobenzoates / pharmacology*
  • Aminophenols / chemistry
  • Aminophenols / pharmacology*
  • Anilides / chemistry
  • Anilides / pharmacology*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / antagonists & inhibitors
  • Drug Resistance, Bacterial / drug effects*
  • Fatty Acid Synthase, Type II / antagonists & inhibitors
  • Molecular Structure
  • Polycyclic Compounds / chemistry
  • Polycyclic Compounds / pharmacology*
  • Streptomyces / chemistry

Substances

  • Aminobenzoates
  • Aminophenols
  • Anilides
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Polycyclic Compounds
  • Fatty Acid Synthase, Type II
  • Adamantane
  • platensimycin
  • platencin